Labiotech.eu

News and Trends 9 Feb 2021

EMA Green Light Sends Oxford Covid-19 Vaccine Into Turbulent Market

As AstraZeneca and the University of Oxford’s Covid-19 vaccine debuts in the EU market this month, supply bottlenecks, viral variants, and political squabbles demonstrate that the quest to develop and distribute Covid-19 vaccines is far from over. The list of approved Covid-19 vaccines in Europe is growing ever longer with the EMA approval of the […]

February 9, 2021 - 6 minutesmins - By Kostas Vavitsas

In Depth 8 Feb 2021

How Next-Generation Gene Therapy Tackles Complex Diseases

Gene therapy has traditionally been applied to well-understood diseases where a single genetic mutation was to blame. A new generation of technology is expanding the potential of gene therapy to treat conditions that were previously unreachable. Since the first gene therapy clinical trials in the 1990s, the technology has made its way into the market […]

February 8, 2021 - 8 minutesmins - By Clara Rodríguez Fernández

gene therapy blood disorder hemophilia b

News and Trends 4 Feb 2021

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers around the world. However, a vital UN deadline for improving global HIV healthcare has slipped away. At the end of January, ViiV Healthcare’s Cabenuva became the first long-acting HIV treatment to be approved by the FDA. This decision, in addition […]

February 4, 2021 - 6 minutesmins - By Anita Chakraverty

In Depth 3 Feb 2021

Detecting Gene-Edited Food: The EU’s Nightmare

The EU imposed stringent controls on the commercialization of gene-edited food back in 2018. Years later, regulators are still working in the dark, with no established tests in place. The EU has some of the strictest food regulations in the world surrounding the cultivation and commercialization of genetically modified organisms (GMOs), which it defines as organisms whose […]

February 3, 2021 - 10 minutesmins - By Jonathan Smith

Interview 1 Feb 2021

Democratized DNA Synthesis: A Game-Changer Against Covid-19

DNA synthesis is one of the pillars of Covid-19 research that has suffered supply disruptions during lockdowns. Thomas Ybert, CEO of DNA Script, discusses the French company’s plans to protect research from future disruptions by giving every lab the ability to synthesize its own DNA molecules. The Covid-19 pandemic has highlighted more than ever the […]

February 1, 2021 - 6 minutesmins - By Jonathan Smith

Single Cell Sequencing Precision Medicine

In Depth 27 Jan 2021

Single-Cell Sequencing: Paving the Way for Precision Medicine

Next-generation sequencing techniques to determine an individual’s unique genetic code gave rise to personalized treatments. Single-cell sequencing is the next step towards making precision medicine more accurate. Each cell in our body is unique. Even genetically identical cells can behave differently in response to a certain treatment. With next-generation sequencing, scientists can study how the […]

January 27, 2021 - 7 minutesmins - By Timothé Cynober

News and Trends 26 Jan 2021

Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms

Since the debut of Imlygic in 2015, no other oncolytic virus cancer therapies have been approved by the FDA and EMA. However, we’re seeing the first signs that the Covid-19 pandemic may help the field get out of the rut. Earlier this month, the Oxford-based firm Theolytics raised €5.6M in a Series A round. This […]

January 26, 2021 - 7 minutesmins - By Jonathan Smith

Water purification industry circular economy

In Depth 20 Jan 2021

Biotech Drives the Water Purification Industry Towards a Circular Economy

Water purification has never been more important, but antiquated methods and a lack of innovation have held the sector back. Biotechnology proposes solutions that bring us one step closer to a true circular economy. Rising populations and pollution levels mean that water purification is now more crucial than ever before. However, much of the industry […]

January 20, 2021 - 10 minutesmins - By Helen Albert

News and Trends 15 Jan 2021

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

This week, the Paris-based Eligo Bioscience became one of a growing number of biotechs to land a big pharma deal focused on the skin microbiome, receiving up to €185M from GlaxoSmithKline (GSK) as they explore a CRISPR-based treatment for acne. Acne is a condition that troubles the majority of adolescents and often persists into adulthood. […]

January 15, 2021 - 4 minutesmins - By Kostas Vavitsas

Inside Labiotech 14 Jan 2021

Labiotech.eu Gets a Facelift for 2021

Happy New Year, and welcome to the new Labiotech.eu! We decided to surprise you with a fresh look to start 2021. In the last couple of months, we’ve been working hard to create a better website experience. Here are some details on what you can expect from this new design. A better reading experience Over […]

January 14, 2021 - 6 minutesmins - By Joachim Eeckhout

Expert Advice 13 Jan 2021

How Much Control Should Investors Have Over Your Biotech Company?

While getting funding from a star investor can be great for business, many biotech entrepreneurs dread the possibility of investors taking control in a situation that eerily resembles a hostile takeover. But it needn’t be that way at all. Biotech founders often complain that investors, especially VCs, demand too much control over company operations. This […]

January 13, 2021 - 6 minutesmins - By Victor Kotsev

Best in Biotech 11 Jan 2021

The 21 European Biotech Companies To Watch in 2021

As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies likely to make a big splash in the biotechnology sector over the next year. There were many memorable moments for the European biotech industry in 2020. The Covid-19 pandemic took over the media and many […]

January 11, 2021 - 11 minutesmins - By Larissa Warneck-Silvestrin

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

EMA Green Light Sends Oxford Covid-19 Vaccine Into Turbulent Market

How Next-Generation Gene Therapy Tackles Complex Diseases

HIV Drug Approvals Lift Hopes Amid Missed UN Targets

Detecting Gene-Edited Food: The EU’s Nightmare

Democratized DNA Synthesis: A Game-Changer Against Covid-19

Single-Cell Sequencing: Paving the Way for Precision Medicine

Oxford’s Covid-19 Vaccine Blazes Trail for Oncolytic Virus Firms

Biotech Drives the Water Purification Industry Towards a Circular Economy

GSK Acne Deal Heralds Growing Interest in Skin Microbiome

Labiotech.eu Gets a Facelift for 2021

How Much Control Should Investors Have Over Your Biotech Company?

The 21 European Biotech Companies To Watch in 2021

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!